In the United States, a research team headed by Philip Wang of the National Institute of Mental Health in Rockville, Maryland, reported similar results last month in the Journal of the American Medical Association . Wang’s team conducted a randomized controlled trial that showed that depression screening – to find workers who could benefit from treatment – was cost-effective, reducing health insurance costs to employers, decreasing absence due to sickness, and increasing job retention and productivity.